Financials RHÖN-KLINIKUM AG Deutsche Boerse AG

Equities

RHKU

US76240P1049

Healthcare Facilities & Services

Delayed Deutsche Boerse AG 02:00:53 2024-07-16 EDT 5-day change 1st Jan Change
5.6 EUR -1.75% Intraday chart for RHÖN-KLINIKUM AG 0.00% +16.18%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,170 1,104 962.6 1,024 669.4 796.6 - -
Enterprise Value (EV) 1 1,034 1,104 1,015 1,024 669.4 796.6 796.6 796.6
P/E ratio 26.9 x 825 x 34.2 x 40.3 x 17.2 x 18.6 x 16.8 x 15.5 x
Yield 1.43% - - - - 2.18% 2.35% 2.61%
Capitalization / Revenue 0.9 x 0.81 x 0.69 x - - 0.52 x 0.51 x 0.5 x
EV / Revenue 0.9 x 0.81 x 0.69 x - - 0.52 x 0.51 x 0.5 x
EV / EBITDA 9.34 x 13.8 x 9.52 x - - 7.23 x 7.18 x 7.08 x
EV / FCF -17,411,969 x -50,433,094 x 48,861,688 x - - - - -
FCF Yield -0% -0% 0% - - - - -
Price to Book 1.01 x - 0.8 x - - 0.61 x 0.6 x 0.58 x
Nbr of stocks (in thousands) 66,938 66,938 66,938 66,938 66,938 66,938 - -
Reference price 2 17.48 16.50 14.38 15.30 10.00 11.90 11.90 11.90
Announcement Date 20-03-24 21-03-25 22-03-24 23-03-30 24-03-28 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,304 1,360 1,402 - - 1,520 1,566 1,605
EBITDA 1 125.3 80.2 101.2 - - 110.1 110.9 112.6
EBIT 1 56.8 10.6 30.52 - - 45.6 50.88 56.17
Operating Margin 4.36% 0.78% 2.18% - - 3% 3.25% 3.5%
Earnings before Tax (EBT) 54.24 3.932 - - - - - -
Net income 1 43.28 1.451 28.3 25.14 38.71 42.83 47.46 51.83
Net margin 3.32% 0.11% 2.02% - - 2.82% 3.03% 3.23%
EPS 2 0.6500 0.0200 0.4200 0.3800 0.5800 0.6400 0.7100 0.7700
Free Cash Flow -67.2 -21.9 19.7 - - - - -
FCF margin -5.15% -1.61% 1.41% - - - - -
FCF Conversion (EBITDA) - - 19.47% - - - - -
FCF Conversion (Net income) - - 69.62% - - - - -
Dividend per Share 2 0.2500 - - - - 0.2600 0.2800 0.3100
Announcement Date 20-03-24 21-03-25 22-03-24 23-03-30 24-03-28 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3
Net sales 1 - 356.1
EBITDA - -
EBIT 1 - 6.145
Operating Margin - 1.73%
Earnings before Tax (EBT) - -
Net income 10.52 -
Net margin - -
EPS 0.1600 -
Dividend per Share - -
Announcement Date 22-08-04 22-11-10
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 52.9 - - - - -
Net Cash position 136 - - - - - - -
Leverage (Debt/EBITDA) - - 0.5228 x - - - - -
Free Cash Flow -67.2 -21.9 19.7 - - - - -
ROE (net income / shareholders' equity) 3.77% - 2.39% - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 17.40 - 17.90 - - 19.50 20.00 20.50
Cash Flow per Share 0.7100 - - - - - - -
Capex 115 97 77.8 - - - - -
Capex / Sales 8.78% 7.13% 5.55% - - - - -
Announcement Date 20-03-24 21-03-25 22-03-24 23-03-30 24-03-28 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11.9 EUR
Average target price
16 EUR
Spread / Average Target
+34.45%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RHK Stock
  4. RHKU Stock
  5. Financials RHÖN-KLINIKUM AG